Sign in to view content

Impact of Initial Monthly Doses of Aflibercept on Visual Outcomes in Eyes With Diabetic Macular Edema in Routine Clinical Practice in the US

Ferhina S Ali, MD, MPH

Video
Published 2023

Related

Safety and Efficacy of Switching to Biosimilar Ranibizumab in Eyes Initially Treated With Reference Ranibizumab for nAMD, DME, or RVO
Nikhil K Bommakanti, MD
Annual Meeting Talks
2024
Intravitreal Injections: Logistics, Safety, and Pearls
Andrew A. Moshfeghi, MD, MBA, FASRS
Webinars and Journal Clubs
2018
Steroid vs. Anti-VEGF for Diabetic Macular Edema Prior to Phacoemulsification (STAMP)
Caesar K. Luo, MD, FASRS
On Demand Cases, Courses, and Papers
2021

Category: Diabetic Retinopathy

See more